APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Testosterone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Transdermal Testosterone Market Outlook and Growth Opportunities 2026

Report ID 174042660420 December 2025190 pages

Choose your research edition.

Industry ResearchTransdermal Testosterone Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Testosterone Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Transdermal Testosterone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Testosterone Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Testosterone Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Transdermal Testosterone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Transdermal Testosterone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transdermal Testosterone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Testosterone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Transdermal Testosterone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Transdermal Testosterone market include Teva, AbbVie, Upsher-Smith Laboratories, Perrigo, Lupin, Endo Pharmaceuticals, Dr. Reddy's Laboratories, Cipla Inc. and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transdermal Testosterone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transdermal Testosterone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Testosterone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Testosterone market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Testosterone Segment by Company

Teva

AbbVie

Upsher-Smith Laboratories

Perrigo

Lupin

Endo Pharmaceuticals

Dr. Reddy's Laboratories

Cipla Inc.

Allergan

Acerus Pharmaceuticals

Transdermal Testosterone Segment by Type

Gel

Patch

Transdermal Testosterone Segment by Application

Late-Onset Hypogonadism

Hypogonadotropic Hypogonadism

Primary Hypogonadism

Transdermal Testosterone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Transdermal Testosterone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Transdermal Testosterone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transdermal Testosterone significant trends, drivers, influence factors in global and regions.

6. To analyze Transdermal Testosterone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Testosterone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Testosterone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Testosterone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Testosterone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transdermal Testosterone industry.

Chapter 3: Detailed analysis of Transdermal Testosterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Transdermal Testosterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Transdermal Testosterone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transdermal Testosterone Industry Trends Table 2. Transdermal Testosterone Industry Drivers Table 3. Transdermal Testosterone Industry Opportunities and Challenges Table 4. Transdermal Testosterone Industry Restraints Table 5. Global Transdermal Testosterone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transdermal Testosterone Revenue Share by Company (2021-2026) Table 7. Global Transdermal Testosterone Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Transdermal Testosterone Sales Volume Share by Company (2021-2026) Table 9. Global Transdermal Testosterone Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Transdermal Testosterone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Transdermal Testosterone Key Company Manufacturing Base & Headquarters Table 12. Global Transdermal Testosterone Company, Product Type & Application Table 13. Global Transdermal Testosterone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Transdermal Testosterone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gel Table 18. Significant Companies of Patch Table 19. Global Transdermal Testosterone Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Transdermal Testosterone Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Transdermal Testosterone Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Transdermal Testosterone Sales Volume Share by Type (2021-2026) Table 23. Global Transdermal Testosterone Sales Volume Share by Type (2027-2032) Table 24. Global Transdermal Testosterone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Transdermal Testosterone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Transdermal Testosterone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Transdermal Testosterone Sales Value Share by Type (2021-2026) Table 28. Global Transdermal Testosterone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Late-Onset Hypogonadism Table 30. Significant Companies of Hypogonadotropic Hypogonadism Table 31. Significant Companies of Primary Hypogonadism Table 32. Global Transdermal Testosterone Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Transdermal Testosterone Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Transdermal Testosterone Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Transdermal Testosterone Sales Volume Share by Application (2021-2026) Table 36. Global Transdermal Testosterone Sales Volume Share by Application (2027-2032) Table 37. Global Transdermal Testosterone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Transdermal Testosterone Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Transdermal Testosterone Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Transdermal Testosterone Sales Value Share by Application (2021-2026) Table 41. Global Transdermal Testosterone Sales Value Share by Application (2027-2032) Table 42. Global Transdermal Testosterone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Transdermal Testosterone Sales by Region (2021-2026) & (W Units) Table 44. Global Transdermal Testosterone Sales Market Share by Region (2021-2026) Table 45. Global Transdermal Testosterone Sales by Region (2027-2032) & (W Units) Table 46. Global Transdermal Testosterone Sales Market Share by Region (2027-2032) Table 47. Global Transdermal Testosterone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Transdermal Testosterone Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Transdermal Testosterone Sales Value Share by Region (2021-2026) Table 50. Global Transdermal Testosterone Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Transdermal Testosterone Sales Value Share by Region (2027-2032) Table 52. Global Transdermal Testosterone Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Transdermal Testosterone Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Transdermal Testosterone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Transdermal Testosterone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Transdermal Testosterone Sales by Country (2021-2026) & (W Units) Table 57. Global Transdermal Testosterone Sales Market Share by Country (2021-2026) Table 58. Global Transdermal Testosterone Sales by Country (2027-2032) & (W Units) Table 59. Global Transdermal Testosterone Sales Market Share by Country (2027-2032) Table 60. Global Transdermal Testosterone Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Transdermal Testosterone Sales Value Market Share by Country (2021-2026) Table 62. Global Transdermal Testosterone Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Transdermal Testosterone Sales Value Market Share by Country (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Teva Transdermal Testosterone Product Portfolio Table 68. Teva Recent Development Table 69. AbbVie Company Information Table 70. AbbVie Business Overview Table 71. AbbVie Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. AbbVie Transdermal Testosterone Product Portfolio Table 73. AbbVie Recent Development Table 74. Upsher-Smith Laboratories Company Information Table 75. Upsher-Smith Laboratories Business Overview Table 76. Upsher-Smith Laboratories Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Upsher-Smith Laboratories Transdermal Testosterone Product Portfolio Table 78. Upsher-Smith Laboratories Recent Development Table 79. Perrigo Company Information Table 80. Perrigo Business Overview Table 81. Perrigo Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Perrigo Transdermal Testosterone Product Portfolio Table 83. Perrigo Recent Development Table 84. Lupin Company Information Table 85. Lupin Business Overview Table 86. Lupin Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Lupin Transdermal Testosterone Product Portfolio Table 88. Lupin Recent Development Table 89. Endo Pharmaceuticals Company Information Table 90. Endo Pharmaceuticals Business Overview Table 91. Endo Pharmaceuticals Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Endo Pharmaceuticals Transdermal Testosterone Product Portfolio Table 93. Endo Pharmaceuticals Recent Development Table 94. Dr. Reddy's Laboratories Company Information Table 95. Dr. Reddy's Laboratories Business Overview Table 96. Dr. Reddy's Laboratories Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolio Table 98. Dr. Reddy's Laboratories Recent Development Table 99. Cipla Inc. Company Information Table 100. Cipla Inc. Business Overview Table 101. Cipla Inc. Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Cipla Inc. Transdermal Testosterone Product Portfolio Table 103. Cipla Inc. Recent Development Table 104. Allergan Company Information Table 105. Allergan Business Overview Table 106. Allergan Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Allergan Transdermal Testosterone Product Portfolio Table 108. Allergan Recent Development Table 109. Acerus Pharmaceuticals Company Information Table 110. Acerus Pharmaceuticals Business Overview Table 111. Acerus Pharmaceuticals Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Acerus Pharmaceuticals Transdermal Testosterone Product Portfolio Table 113. Acerus Pharmaceuticals Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Transdermal Testosterone Distributors List Table 117. Transdermal Testosterone Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Transdermal Testosterone Product Image Figure 2. Global Transdermal Testosterone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Testosterone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Transdermal Testosterone Sales (2021-2032) & (W Units) Figure 5. Global Transdermal Testosterone Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Transdermal Testosterone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gel Image Figure 10. Patch Image Figure 11. Global Transdermal Testosterone Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Transdermal Testosterone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Transdermal Testosterone Sales Volume Share by Type (2021-2032) Figure 14. Global Transdermal Testosterone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Transdermal Testosterone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Transdermal Testosterone Sales Value Share by Type (2021-2032) Figure 17. Late-Onset Hypogonadism Image Figure 18. Hypogonadotropic Hypogonadism Image Figure 19. Primary Hypogonadism Image Figure 20. Global Transdermal Testosterone Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Transdermal Testosterone Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Transdermal Testosterone Sales Volume Share by Application (2021-2032) Figure 23. Global Transdermal Testosterone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Transdermal Testosterone Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Transdermal Testosterone Sales Value Share by Application (2021-2032) Figure 26. Global Transdermal Testosterone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Transdermal Testosterone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Transdermal Testosterone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Transdermal Testosterone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Transdermal Testosterone Sales Value (2021-2032) & (US$ Million) Figure 31. North America Transdermal Testosterone Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Transdermal Testosterone Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Transdermal Testosterone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Transdermal Testosterone Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Transdermal Testosterone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Transdermal Testosterone Sales Value (2021-2032) & (US$ Million) Figure 37. South America Transdermal Testosterone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Transdermal Testosterone Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Transdermal Testosterone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Transdermal Testosterone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Transdermal Testosterone Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Transdermal Testosterone Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Gel
  • Patch
Applications
  • Late-Onset Hypogonadism
  • Hypogonadotropic Hypogonadism
  • Primary Hypogonadism
Companies covered
  • Teva
  • AbbVie
  • Upsher-Smith Laboratories
  • Perrigo
  • Lupin
  • Endo Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Cipla Inc.
  • Allergan
  • Acerus Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transdermal Testosterone Sales Value (2021-2032)
  4. 1.2.2 Global Transdermal Testosterone Sales Volume (2021-2032)
  5. 1.2.3 Global Transdermal Testosterone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Transdermal Testosterone Market Dynamics
  1. 2.1 Transdermal Testosterone Industry Trends
  2. 2.2 Transdermal Testosterone Industry Drivers
  3. 2.3 Transdermal Testosterone Industry Opportunities and Challenges
  4. 2.4 Transdermal Testosterone Industry Restraints
3 Transdermal Testosterone Market by Company
  1. 3.1 Global Transdermal Testosterone Company Revenue Ranking in 2025
  2. 3.2 Global Transdermal Testosterone Revenue by Company (2021-2026)
  3. 3.3 Global Transdermal Testosterone Sales Volume by Company (2021-2026)
  4. 3.4 Global Transdermal Testosterone Average Price by Company (2021-2026)
  5. 3.5 Global Transdermal Testosterone Company Ranking (2024-2026)
  6. 3.6 Global Transdermal Testosterone Company Manufacturing Base and Headquarters
  7. 3.7 Global Transdermal Testosterone Company Product Type and Application
  8. 3.8 Global Transdermal Testosterone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Transdermal Testosterone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Transdermal Testosterone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Transdermal Testosterone Market by Type
  1. 4.1 Transdermal Testosterone Type Introduction
  2. 4.1.1 Gel
  3. 4.1.2 Patch
  4. 4.2 Global Transdermal Testosterone Sales Volume by Type
  5. 4.2.1 Global Transdermal Testosterone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Transdermal Testosterone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Transdermal Testosterone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Transdermal Testosterone Sales Value by Type
  9. 4.3.1 Global Transdermal Testosterone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Transdermal Testosterone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Transdermal Testosterone Sales Value Share by Type (2021-2032)
5 Transdermal Testosterone Market by Application
  1. 5.1 Transdermal Testosterone Application Introduction
  2. 5.1.1 Late-Onset Hypogonadism
  3. 5.1.2 Hypogonadotropic Hypogonadism
  4. 5.1.3 Primary Hypogonadism
  5. 5.2 Global Transdermal Testosterone Sales Volume by Application
  6. 5.2.1 Global Transdermal Testosterone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transdermal Testosterone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Transdermal Testosterone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Transdermal Testosterone Sales Value by Application
  10. 5.3.1 Global Transdermal Testosterone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Transdermal Testosterone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Transdermal Testosterone Sales Value Share by Application (2021-2032)
6 Transdermal Testosterone Regional Sales and Value Analysis
  1. 6.1 Global Transdermal Testosterone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transdermal Testosterone Sales by Region (2021-2032)
  3. 6.2.1 Global Transdermal Testosterone Sales by Region: 2021-2026
  4. 6.2.2 Global Transdermal Testosterone Sales by Region (2027-2032)
  5. 6.3 Global Transdermal Testosterone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Transdermal Testosterone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Transdermal Testosterone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Transdermal Testosterone Sales Value by Region (2027-2032)
  9. 6.5 Global Transdermal Testosterone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Transdermal Testosterone Sales Value (2021-2032)
  12. 6.6.2 North America Transdermal Testosterone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Transdermal Testosterone Sales Value (2021-2032)
  15. 6.7.2 Europe Transdermal Testosterone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Transdermal Testosterone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Transdermal Testosterone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Transdermal Testosterone Sales Value (2021-2032)
  21. 6.9.2 South America Transdermal Testosterone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Transdermal Testosterone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Transdermal Testosterone Sales Value Share by Country, 2025 VS 2032
7 Transdermal Testosterone Country-level Sales and Value Analysis
  1. 7.1 Global Transdermal Testosterone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transdermal Testosterone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Transdermal Testosterone Sales by Country (2021-2032)
  4. 7.3.1 Global Transdermal Testosterone Sales by Country (2021-2026)
  5. 7.3.2 Global Transdermal Testosterone Sales by Country (2027-2032)
  6. 7.4 Global Transdermal Testosterone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Transdermal Testosterone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Transdermal Testosterone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Transdermal Testosterone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Transdermal Testosterone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Transdermal Testosterone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Transdermal Testosterone Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 AbbVie
  8. 8.2.1 AbbVie Company Information
  9. 8.2.2 AbbVie Business Overview
  10. 8.2.3 AbbVie Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Transdermal Testosterone Product Portfolio
  12. 8.2.5 AbbVie Recent Developments
  13. 8.3 Upsher-Smith Laboratories
  14. 8.3.1 Upsher-Smith Laboratories Company Information
  15. 8.3.2 Upsher-Smith Laboratories Business Overview
  16. 8.3.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Upsher-Smith Laboratories Transdermal Testosterone Product Portfolio
  18. 8.3.5 Upsher-Smith Laboratories Recent Developments
  19. 8.4 Perrigo
  20. 8.4.1 Perrigo Company Information
  21. 8.4.2 Perrigo Business Overview
  22. 8.4.3 Perrigo Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Perrigo Transdermal Testosterone Product Portfolio
  24. 8.4.5 Perrigo Recent Developments
  25. 8.5 Lupin
  26. 8.5.1 Lupin Company Information
  27. 8.5.2 Lupin Business Overview
  28. 8.5.3 Lupin Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lupin Transdermal Testosterone Product Portfolio
  30. 8.5.5 Lupin Recent Developments
  31. 8.6 Endo Pharmaceuticals
  32. 8.6.1 Endo Pharmaceuticals Company Information
  33. 8.6.2 Endo Pharmaceuticals Business Overview
  34. 8.6.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Endo Pharmaceuticals Transdermal Testosterone Product Portfolio
  36. 8.6.5 Endo Pharmaceuticals Recent Developments
  37. 8.7 Dr. Reddy's Laboratories
  38. 8.7.1 Dr. Reddy's Laboratories Company Information
  39. 8.7.2 Dr. Reddy's Laboratories Business Overview
  40. 8.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolio
  42. 8.7.5 Dr. Reddy's Laboratories Recent Developments
  43. 8.8 Cipla Inc.
  44. 8.8.1 Cipla Inc. Company Information
  45. 8.8.2 Cipla Inc. Business Overview
  46. 8.8.3 Cipla Inc. Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Cipla Inc. Transdermal Testosterone Product Portfolio
  48. 8.8.5 Cipla Inc. Recent Developments
  49. 8.9 Allergan
  50. 8.9.1 Allergan Company Information
  51. 8.9.2 Allergan Business Overview
  52. 8.9.3 Allergan Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Allergan Transdermal Testosterone Product Portfolio
  54. 8.9.5 Allergan Recent Developments
  55. 8.10 Acerus Pharmaceuticals
  56. 8.10.1 Acerus Pharmaceuticals Company Information
  57. 8.10.2 Acerus Pharmaceuticals Business Overview
  58. 8.10.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Acerus Pharmaceuticals Transdermal Testosterone Product Portfolio
  60. 8.10.5 Acerus Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transdermal Testosterone Value Chain Analysis
  2. 9.1.1 Transdermal Testosterone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transdermal Testosterone Sales Mode & Process
  6. 9.2 Transdermal Testosterone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transdermal Testosterone Distributors
  9. 9.2.3 Transdermal Testosterone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst